Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 4Phase NA 2Phase EARLY_PHASE1 2Phase 2/3 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Depression 4Anxiety Disorders 3Pancreatic Neoplasms 2Neoplasms 2Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fatigue 1

Interventions

Cyclophosphamide 5Positron Emission Tomography Computed Tomography 4pembrolizumab 3Topotecan 2Surveys and Questionnaires 2Psilocybin 2Midazolam 2Methods 2Ketoconazole 2Ketamine 2temsirolimus 1posaconazole 1poly ICLC 1parathyroid hormone-related peptide (1-36) 1lavender oil 1jojoba wax 1ginger extract 1fluoromisonidazole 1fludarabine phosphate 1fludarabine 1fluciclovine F-18 1evolocumab 1etoposide phosphate 1beta-Glucans 1Whole-Body Irradiation 1Vincristine 1Varenicline 1Transplantation 1Transcranial Direct Current Stimulation 1Tetrahydrouridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neoplasms × Ketamine × Clear all
NCT02317341 2019-03-20

Effect of Ketamine on Fatigue Following Cancer Therapy

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated
2 enrolled

Fatigue, Neoplasms

NCT02836288 2018-11-06

Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Completed
4 enrolled

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡